|
ES2032831T5
(es)
|
1986-08-19 |
2001-02-16 |
Genentech Inc |
Dispositivo y dispersion para suministro intrapulmonar de factores de crecimiento polipeptidos y citoquinas.
|
|
JPH01215289A
(ja)
|
1988-02-22 |
1989-08-29 |
Toa Nenryo Kogyo Kk |
遺伝子組換えによる正常ヒト血清アルブミンａの製造方法
|
|
FR2649991B2
(fr)
|
1988-08-05 |
1994-03-04 |
Rhone Poulenc Sante |
Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
|
|
US5728553A
(en)
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
|
AU696387B2
(en)
|
1994-05-18 |
1998-09-10 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions for the dry powder formulation of interferons
|
|
DE4417598A1
(de)
|
1994-05-19 |
1995-12-14 |
Max Planck Gesellschaft |
Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen
|
|
WO1996023879A1
(en)
|
1995-01-30 |
1996-08-08 |
Terrapin Technologies, Inc. |
Glubodies - multiplicities of proteins capable of binding a variety of small molecules
|
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
|
US6620413B1
(en)
|
1995-12-27 |
2003-09-16 |
Genentech, Inc. |
OB protein-polymer chimeras
|
|
DE19641876B4
(de)
|
1996-10-10 |
2011-09-29 |
Iba Gmbh |
Streptavidinmuteine
|
|
WO1998016873A1
(en)
|
1996-10-14 |
1998-04-23 |
Firm Forsat Ltd. |
Method for preparing dispersions of chromogenic components
|
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
|
CA2233725A1
(en)
|
1998-03-31 |
1999-09-30 |
Hemosol Inc. |
Hemoglobin-hydroxyethyl starch complexes
|
|
JP3839667B2
(ja)
|
1998-06-08 |
2006-11-01 |
エフ．ホフマン−ラ ロシュ アーゲー |
慢性Ｃ型肝炎の処置のためのＰｅｇ−ＩＮＦ−アルファ及びリバビリンの使用
|
|
US6403564B1
(en)
|
1998-10-16 |
2002-06-11 |
Schering Corporation |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
|
|
DE19926068C1
(de)
|
1999-06-08 |
2001-01-11 |
Arne Skerra |
Muteine des Bilin-Bindungsproteins
|
|
US7211395B2
(en)
|
2001-03-09 |
2007-05-01 |
Dyax Corp. |
Serum albumin binding moieties
|
|
WO2003029462A1
(en)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
|
|
US7118915B2
(en)
|
2001-09-27 |
2006-10-10 |
Pieris Proteolab Ag |
Muteins of apolipoprotein D
|
|
US7691970B2
(en)
|
2003-08-25 |
2010-04-06 |
Pieris Ag |
Muteins of a bilin-binding protein with affinity for a given target
|
|
WO2005019255A1
(en)
|
2003-08-25 |
2005-03-03 |
Pieris Proteolab Ag |
Muteins of tear lipocalin
|
|
JP2007284351A
(ja)
|
2004-07-27 |
2007-11-01 |
Osaka Bioscience Institute |
アミロイド蛋白質の凝集を抑制する物質とその作用
|
|
US7892827B2
(en)
|
2004-11-26 |
2011-02-22 |
Pieris Ag |
Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
|
|
AU2006294644A1
(en)
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
|
EP2225268B1
(en)
|
2007-10-19 |
2012-08-29 |
Abbott Laboratories |
Immunoassays and kits for the detection of ngal
|
|
US8420051B2
(en)
|
2008-06-24 |
2013-04-16 |
Technische Universitaet Meunchen |
Muteins of hNGAL and related proteins with affinity for a given target
|
|
WO2010054025A1
(en)
*
|
2008-11-05 |
2010-05-14 |
Abbott Laboratories |
Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use
|
|
BR112012013662B1
(pt)
|
2009-12-07 |
2022-08-02 |
Pieris Pharmaceuticals Gmbh |
Muteínas de lipocalina associada à gelatinase de neutrófilo humano (lcn2, hngal), seu uso e seus métodos de geração e produção, molécula de ácido nucleico, célula hospedeira, composição farmacêutica e kit de diagnóstico ou analítico
|
|
AU2011263786B2
(en)
*
|
2010-06-08 |
2014-11-13 |
Astrazeneca Ab |
Tear lipocalin muteins binding IL-4 R alpha
|
|
AU2011290751B2
(en)
|
2010-08-16 |
2015-08-13 |
Pieris Ag |
Binding proteins for Hepcidin
|
|
CA2817779C
(en)
|
2010-11-15 |
2019-02-19 |
Pieris Pharmaceuticals Gmbh |
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
|
|
PT3495392T
(pt)
*
|
2011-05-20 |
2021-09-22 |
H Lundbeck As |
Composições anti-cgrp e a sua utilização
|
|
EP2920202B1
(en)
*
|
2012-11-19 |
2018-08-29 |
Pieris Pharmaceuticals GmbH |
Novel specific-binding polypeptides and uses thereof
|
|
EP2925337B1
(en)
*
|
2012-11-21 |
2019-07-03 |
The Trustees of Columbia University in the City of New York |
Mutant ngal proteins and uses thereof
|
|
MX378344B
(es)
|
2014-03-21 |
2025-03-10 |
Teva Pharmaceuticals Int Gmbh |
Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos.
|
|
US10556945B2
(en)
*
|
2014-03-21 |
2020-02-11 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
WO2015176017A1
(en)
|
2014-05-16 |
2015-11-19 |
Salk Institute For Biological Studies |
Compositions and methods for treating metabolic disorders
|
|
SG11201705278QA
(en)
|
2015-01-28 |
2017-07-28 |
Pieris Pharmaceuticals Gmbh |
Novel proteins specific for angiogenesis
|
|
EP3259282A1
(en)
|
2015-02-18 |
2017-12-27 |
Sanofi |
Novel proteins specific for pyoverdine and pyochelin
|
|
PH12017501583B1
(en)
|
2015-05-04 |
2023-01-20 |
Pieris Pharmaceuticals Gmbh |
Novel proteins specific for cd137
|
|
EP3298029A1
(en)
|
2015-05-18 |
2018-03-28 |
Pieris Pharmaceuticals GmbH |
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
|
|
TW201725212A
(zh)
|
2015-12-10 |
2017-07-16 |
第一三共股份有限公司 |
特異性於降鈣素基因相關胜肽的新穎蛋白
|